Clinical Trial Update: Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial assessing the safety of lovastatin in individuals with Neurofibromatosis type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Neurofibromatosis 1 | Phase 1 | Status: COMPLETED